BRAF V600E as a target may not be limited to only PTC with a BRAF activating mutation, since BRAF and other RAF kinases are activated by other oncogenes involved in follicular and papillary carcinoma [7]. The gene discussed is RAF1; the disease is thyroid gland papillary carcinoma.